| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $631.3M | — | -3.1% |
| Cost of Revenue | $175.7M | — | -8.5% |
| Gross Profit | $455.6M | — | -0.8% |
| R&D Expense | $99.1M | — | -10.4% |
| SG&A Expense | $62.5M | — | -22.1% |
| Operating Income | $119.8M | — | +636.8% |
| Pre-tax Income | $129.3M | — | +487.9% |
| Income Tax | $24.6M | — | +31.0% |
| Net Income | $69.7M | — | +233.8% |
| EPS (Basic) | $0.72 | — | +246.9% |
| EPS (Diluted) | $0.60 | — | +222.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $1.21B | -13.0% | +87.1% |
| Accounts Receivable | $8.7M | +0.2% | -2.6% |
| Current Assets | $2.11B | +7.7% | +90.3% |
| Total Assets | $2.68B | -5.2% | +26.4% |
| Current Liabilities | $1.25B | -8.3% | +140.9% |
| Long-term Debt | $2.33B |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | $80.7M | — | +64.2% |
| Capital Expenditures | $1.5M | — | -54.3% |
| Investing Cash Flow | -$16.5M | — | +20.1% |
| Financing Cash Flow | -$158.4M | — | +22.6% |
| Free Cash Flow | $79.3M | — | +72.5% |
| +2.0% |
| Total Liabilities | $3.82B | -2.7% | +26.0% |
| Stockholders' Equity | -$1.14B | -3.5% | -24.9% |